Authors


Guia Bertuzzi

Latest:

Granulation: evolving slowly but surely

Granulation is the most crucial step in the manufacture of solid dosage forms.


Graham Rideal

Latest:

The Importance Of Filter Testing

Graham Rideal of Whitehouse Scientific explains the importance of filter testing and offers some considerations with regards to choosing filter test methods.


John B. Kowalski

Latest:

Establishing a Minimum Incubation Time for Biological Indicators

The industry lacks an accepted method for establishing a minimum incubation time (MIT) of less than seven days for biological indicators (BIs). The authors propose an MIT method that provides a means for reproducible determination of BI grow-out time.


Jürgen Schafer

Latest:

Packaging: The Experts' View

Leading European experts from the pharmaceutical packaging industry explain how they are coping with industry trends.


Peter Houston

Latest:

Pharma's Facebook

Social media is big news. From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minutetominute within huge databases of content that they themselves create.


Dipankar Dey

Latest:

Coding technologies: breaking down the barriers

Tablet coding or identification is based either on the detection system being overt (visual to the naked eye) or covert (non-visual). The coding of tablets is obvious at an overt level because of size, shape, colour and logo design.


Satti Phanikumar Reddy

Latest:

The combination drugs debate: Incompatibility problems can be overcome

Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.


Paul Lopolito

Latest:

Considerations for Cleaning Lipid Nanoparticles

This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.


Beatriz San Martin

Latest:

Embryonic stem cells: the moral dilemma of patentability and funding

Human embryonic stem cells are of immense interest to researchers because of their ability to potentially develop into any kind of tissue.


Raul Soikes

Latest:

Prefilled Syringes: Challenges, Innovations And Market

The pharma industry is constantly seeking drug delivery technologies that can increase compliance, improve the quality of delivered care, reduce medication errors and reduce the possibility of admixture-related contamination.


Praveen Kumar

Latest:

Stabilization of Interferon alpha-2b in a Topical Cream

The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.


Rebecca Vangenechten

Latest:

Integrating PAT into biopharmaceutical research: a case study

This case study describes the implementation of process analytical technology on the cultivation process step of a whole-cell vaccine against whooping cough disease.


Rajesh Dubey

Latest:

The combination drugs debate: Incompatibility problems can be overcome

Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.


Robert J. Thomas

Latest:

Large-Scale Manufacture of Therapeutic Human Stem Cells

Large-scale manufacturing of human stem cells for therapeutic use is a leap in technology and science for the current biotechnology industry.


R. Harris Cummings, PhD

Latest:

The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing

A knowledgeable and experienced contract service provider can help in the development and success of an inhalation drug product.


BP Nicolas Voute

Latest:

Qualification and Validation of Single-Use Shipping Systems

In this article, the authors look at the limitations of the validation for a single-use shipping system and provide a perspective on what shipping validation means.


Adriana Salvatore

Latest:

The Death of the Drug Dossier

For nearly 40 years, drug dossiers have supported the quality, safety and risk/benefits of medicinal products. However, electronic technological advances mean that the dossier will soon be a thing of the past - being replaced by e-documents that can be reviewed and approved online by regulators, under the scrutiny of patient groups and with the final blessing of purchasers, as this article examines.


Andrea Rainoldi

Latest:

Dynamic avalanching accurately assesses flowability and quality

Cefaclor is a β-lactam cephalosporin antibiotic that has a wide particle size distribution. Because of the nonporous nature of the material, the specific surface area value accounts for a significant amount of fine particles possibly present in the samples under analysis.


Piero Tomasi

Latest:

Packaging: The Experts' View

Leading European experts from the pharmaceutical packaging industry explain how they are coping with industry trends.


Malcolm Ross

Latest:

The combination drugs debate: unstable and unpatentable

Combination products have been researched and administered for many years, some successfully and others not.


Patrick Bennett

Latest:

Identification and Quantification of Trace-Level Protein Impurities

The authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.


Michael C. Olson

Latest:

Quality by Design for Generic Drugs

The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.



Heather Simmerman

Latest:

Application of the Weisberg t-test for Outliers

Determining whether a data point is an "outlier" - a result that does not fit, is too high or too low, is extreme or discordant - is difficult when using small data sets, such as the data from three, four or five conformance runs. In this article, the authors demonstrate that the Weisberg t-test is a powerful tool for detecting deviations in small data sets.


Ramesh Panchagnula, PhD

Latest:

Mefenamic acid: new polymorph or crystal defect?

Mefenamic acid has variable bioavailability and tabletting issues because of its hydrophobic nature and poor material characteristics. Recrystallization of mefenamic acid was performed from three different solvent–solvent mixtures under differing conditions. The crystals obtained were screened for the existence of new crystal properties or polymorphic forms, then characterized further.


Nikunjana A. Patel

Latest:

The Formulation and Evaluation of Topical Berberine-Hydrochloride Products

The authors sought to prepare a topical formulation of berberine hydrochloride for the effective and controlled management of inflammation and skin infections.


Andreas Weiler

Latest:

Western CMOs Rise Again, Face New Challenges

Increased competition from CMOs in Asia means that Western CMOs need to understand fundamental changes in the market.


Thomas Kutz

Latest:

Filling of Asthma Inhalers with Liquid Nitrogen: Cryogenic Product Cooling of Aerosol Propellants

This case study describes how a major pharmaceutical manufacturer was equipped with four filling lines, for metered dose inhalers, supplied with a nitrogen cooling system to prevent spontaneous vaporization of the propellant gas. By doing so, a cost-effective and environmentally friendly solution was provided to a hazardous situation, which also complied with regulatory directives.


Marianna Foldvari

Latest:

Stabilization of Interferon alpha-2b in a Topical Cream

The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.


Russell E. Madsen Jr.

Latest:

Lies That Environmental Monitoring Systems Tell

Environmental monitoring, which operates below the limit of detection, is little more than a rote exercise that provides limited real value. So why does it figure so prominently in current regulatory requirements for aseptic manufacturing?